NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity

---- Acknowledgements -----

This research was supported by the National Institute of Aging of the National Institutes of Health under grant number R01 AG043560 to the National Bureau of Economic Research. In addition, Mr. Shapiro's research was supported in part by a Health and Aging Fellowship from the National Institute of Aging via the National Bureau of Economic Research , Grant Number T32-AG000186. The statements, findings, conclusions, views and opinions contained and expressed herein are based in part on data provided under license from IMS Health Incorporated Information Services: National Prescription Audit (June 2009-May 2013), IMS Health Incorporated. All Rights Reserved. The statements, findings, conclusions, views, and opinions contained and expressed herein are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health, IMS Health Incorporated, any of its affiliated or subsidiary entities, the National Bureau of Economic Research, or the institutions with whom the authors are affiliated.

---- Disclosure of Financial Relationships for Bradley T. Shapiro -----

Mr. Shapiro's research is also supported by the National Science Foundation Graduate Research Fellowship under Grant Number 1122374

return to bibliography page

 
Publications
Activities
Meetings
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us